{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:18:45Z","timestamp":1768922325281,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10585-024-10304-3","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T14:02:13Z","timestamp":1722520933000},"page":"679-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)"],"prefix":"10.1007","volume":"41","author":[{"given":"Francesco","family":"Cuccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Badellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Borghetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Marvaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Montesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pontoriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"10304_CR1","doi-asserted-by":"publisher","first-page":"115783","DOI":"10.1016\/j.bone.2020.115783","volume":"158","author":"C Ryan","year":"2022","unstructured":"Ryan C, Stoltzfus KC, Horn S, Chen H, Louie AV, Lehrer EJ et al (2022) Epidemiology of bone metastases. Bone 158:115783. https:\/\/doi.org\/10.1016\/j.bone.2020.115783","journal-title":"Bone"},{"key":"10304_CR2","doi-asserted-by":"publisher","unstructured":"Rong Y, Ding X, Daly ME, Hypofractionation (2023 Feb) 25 years of evolution in medical physics and a glimpse of the future. Med Phys 9. https:\/\/doi.org\/10.1002\/mp.16270","DOI":"10.1002\/mp.16270"},{"issue":"1","key":"10304_CR3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18\u2013e28. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"10304_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","volume":"22","author":"A Chalkidou","year":"2021","unstructured":"Chalkidou A, Macmillan T, Grzeda MT, Peacock J, Summers J, Eddy S, Coker B, Patrick H, Powell H, Berry L, Webster G, Ostler P, Dickinson PD, Hatton MQ, Henry A, Keevil S, Hawkins MA, Slevin N, van As N (2021) Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study. Lancet Oncol 22(1):98\u2013106. https:\/\/doi.org\/10.1016\/S1470-2045(20)30537-4","journal-title":"Lancet Oncol"},{"issue":"25","key":"10304_CR5","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al (2020) Stereotactic ablative radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 38(25):2830\u20132838. https:\/\/doi.org\/10.1200\/JCO.20.00818","journal-title":"J Clin Oncol"},{"issue":"10422","key":"10304_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"CJ Tsai","year":"2024","unstructured":"Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN, CURB Study Group (2024) Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (consolidative use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study. Lancet 403(10422):171\u2013182. https:\/\/doi.org\/10.1016\/S0140-6736(23)01857-3","journal-title":"Lancet"},{"issue":"36","key":"10304_CR7","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1200\/JCO.23.00985","volume":"41","author":"G Francolini","year":"2023","unstructured":"Francolini G, Gaetano Allegra A, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D\u2019Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L, ARTO Working Group members (2023) Stereotactic body Radiation Therapy and Abiraterone acetate for patients affected by Oligometastatic Castrate-resistant prostate Cancer: a Randomized Phase II Trial (ARTO). J Clin Oncol 41(36):5561\u20135568. https:\/\/doi.org\/10.1200\/JCO.23.00985","journal-title":"J Clin Oncol"},{"issue":"10","key":"10304_CR8","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1002\/cam4.2366","volume":"8","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, Yu J, Nuerjiang S, Li Z, Wang D, Wang X, Zhang J, Xie C (2019) Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer. Cancer Med 8(10):4605\u20134614. https:\/\/doi.org\/10.1002\/cam4.2366","journal-title":"Cancer Med"},{"issue":"2","key":"10304_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2020.12.045","volume":"110","author":"M Guckenberger","year":"2021","unstructured":"Guckenberger M, Mantel F, Sweeney RA, Hawkins M, Belderbos J, Ahmed M et al (2021) Long-term results of dose-intensified fractionated stereotactic body Radiation Therapy (SBRT) for painful spinal metastases. Int J Radiat Oncol Biol Phys 110(2):348\u2013357. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10304_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","volume":"128","author":"T Sprave","year":"2018","unstructured":"Sprave T, Verma V, F\u00f6rster R, Schlampp I, Bruckner T, Bostel T et al (2018) Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol 128(2):274\u2013282. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.030","journal-title":"Radiother Oncol"},{"issue":"7","key":"10304_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal A, Myrehaug SD, Siva S, Masucci GL, Maralani PJ, Brundage M et al (2021) Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. Lancet Oncol 22(7):1023\u20131033. https:\/\/doi.org\/10.1016\/S1470-2045(21)00196-0","journal-title":"Lancet Oncol"},{"key":"10304_CR12","doi-asserted-by":"publisher","unstructured":"Zeng KL, Myrehaug S, Soliman H, Husain ZA, Tseng CL, Detsky J et al Mature local control and reirradiation rates comparing spine stereotactic body radiotherapy to Conventional Palliative External Beam Radiotherapy. Int J Radiat Oncol Biol Phys 2022 Jun 5:S0360\u20133016(22)00550\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.043","DOI":"10.1016\/j.ijrobp.2022.05.043"},{"issue":"4","key":"10304_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW (2014) Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 67(4):401\u2013409. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.12.002","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10304_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","volume":"33","author":"M Guckenberger","year":"2023","unstructured":"Guckenberger M, Dahele M, Ong WL, Sahgal A (2023) Stereotactic body Radiation Therapy for spinal metastases: benefits and limitations. Semin Radiat Oncol 33(2):159\u2013171. https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.006","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"10304_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","volume":"114","author":"S Harrow","year":"2022","unstructured":"Harrow S, Palma DA, Olson R, Gaede S, Louie AV, Haasbeek C et al (2022) Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): extended long-term outcomes. Int J Radiat Oncol Biol Phys 114(4):611\u2013616. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10304_CR16","doi-asserted-by":"publisher","unstructured":"McClelland S 3rd, Sun Y, Spratt DE (2023) Spine patient optimal Radiosurgery treatment for symptomatic metastatic neoplasms (SPORTSMEN): a randomized phase II study protocol. Rep Pract Oncol Radiother 28(3):379\u2013388. https:\/\/doi.org\/10.5603\/RPOR.a2023.0037","DOI":"10.5603\/RPOR.a2023.0037"},{"key":"10304_CR17","doi-asserted-by":"publisher","unstructured":"Guninski RS, Cuccia F, Alongi F, Andratschke N, Belka C, Bellut D, Dahele M, Josipovic M, Kroese TE, Mancosu P, Minniti G, Niyazi M, Ricardi U, Munck Af Rosenschold P, Sahgal A, Tsang Y, Verbakel WFAR, Guckenberger M Efficacy and safety of SBRT for spine metastases: a systematic review and meta-analysis for preparation of an ESTRO practice guideline. Radiother Oncol 2023 Nov 2:109969. https:\/\/doi.org\/10.1016\/j.radonc.2023.109969","DOI":"10.1016\/j.radonc.2023.109969"},{"issue":"12","key":"10304_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.clon.2023.09.001","volume":"35","author":"F Cuccia","year":"2023","unstructured":"Cuccia F, Pastorello E, Franzese C, Belgioia L, Bignardi M, Federico M, Figlia V, Giaj Levra N, Badellino S, Borghetti P, Marvaso G, Montesi G, Pontoriero A, Fazio I, Ferrera G, Alongi F, Scorsetti M (2023) Stereotactic body Radiotherapy for Spine oligometastases: a Multicentre Retrospective Study from the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Clin Oncol (R Coll Radiol) 35(12):794\u2013800. https:\/\/doi.org\/10.1016\/j.clon.2023.09.001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10304_CR19","doi-asserted-by":"publisher","unstructured":"Guckenberger M, Andratschke N, Belka C, Bellut D, Cuccia F, Dahele M, Guninski RS, Josipovic M, Mancosu P, Minniti G, Niyazi M, Ricardi U, Munck Af Rosenschold P, Sahgal A, Tsang Y, Verbakel W, Alongi F ESTRO clinical practice guideline: stereotactic body radiotherapy for spine metastases. Radiother Oncol 2023 Nov 2:109966. https:\/\/doi.org\/10.1016\/j.radonc.2023.109966","DOI":"10.1016\/j.radonc.2023.109966"},{"issue":"5","key":"10304_CR20","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","volume":"83","author":"BW Cox","year":"2012","unstructured":"Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, Sheehan J, Gerszten PC, Chang E, Gibbs I, Soltys S, Sahgal A, Deasy J, Flickinger J, Quader M, Mindea S, Yamada Y (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83(5):e597\u2013605. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10304_CR21","doi-asserted-by":"publisher","first-page":"110235","DOI":"10.1016\/j.radonc.2024.110235","volume":"195","author":"SM Christ","year":"2024","unstructured":"Christ SM, Alongi F, Ricardi U, Scorsetti M, Livi L, Balermpas P, Lievens Y, Braam P, Jereczek-Fossa BA, Stellamans K, Ratosa I, Widder J, Peulen H, Dirix P, Bral S, Ramella S, Hemmatazad H, Khanfir K, Geets X, Jeene P, Zilli T, Fournier B, Ivaldi GB, Clementel E, Fortpied C, Oppong FB, Ost P, Guckenberger M (2024) Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study. Radiother Oncol 195:110235. https:\/\/doi.org\/10.1016\/j.radonc.2024.110235","journal-title":"Radiother Oncol"},{"issue":"3","key":"10304_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ijrobp.2022.09.076","volume":"115","author":"KL Zeng","year":"2023","unstructured":"Zeng KL, Abugarib A, Soliman H, Myrehaug S, Husain ZA, Detsky J, Ruschin M, Karotki A, Atenafu EG, Larouche J, Campbell M, Maralani P, Sahgal A, Tseng CL (2023) Dose-escalated 2-Fraction spine stereotactic body Radiation Therapy: 28 gy Versus 24 gy in 2 daily fractions. Int J Radiat Oncol Biol Phys 115(3):686\u2013695. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.09.076","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10304_CR23","doi-asserted-by":"publisher","unstructured":"Pontoriero A, Iat\u00ec G, Cacciola A, Conti A, Brogna A, Siragusa C, Ferini G, Dav\u00ec V, Tamburella C, Molino L, Cambareri D, Severo C, Parisi S, Settineri N, Ielo I, Pergolizzi S (2020 Jan-Dec) Stereotactic body Radiation Therapy with Simultaneous Integrated Boost in patients with spinal metastases. Technol Cancer Res Treat 19:1533033820904447. https:\/\/doi.org\/10.1177\/1533033820904447","DOI":"10.1177\/1533033820904447"},{"issue":"2","key":"10304_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00066-023-02082-w","volume":"200","author":"M Waltenberger","year":"2024","unstructured":"Waltenberger M, Vogel MME, Bernhardt D, M\u00fcnch S, Dobiasch S, Redmond KJ, Lo SS, Acker G, Fehlings MG, Ringel F, Vajkoczy P, Meyer B, Combs SE (2024) Radiotherapy concepts for spinal metastases-results from an online survey among radiation oncologists of the German Society for Radiation Oncology. Strahlenther Onkol 200(2):159\u2013174. https:\/\/doi.org\/10.1007\/s00066-023-02082-w","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"10304_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/biomedicines8120548","volume":"8","author":"B Pichon","year":"2020","unstructured":"Pichon B, Rousseau C, Blanc-Lapierre A, Delpon G, Ferrer L, Libois V et al (2020) Targeting stereotactic body radiotherapy on metabolic PET- and Immuno-PET-Positive vertebral metastases. Biomedicines 8(12):548. https:\/\/doi.org\/10.3390\/biomedicines8120548","journal-title":"Biomedicines"},{"issue":"2","key":"10304_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12094-022-02951-3","volume":"25","author":"R Di Franco","year":"2023","unstructured":"Di Franco R, Pezzulla D, Arcidiacono F, Pontoriero A, Cellini F, Belgioia L, Borzillo V, Lillo S, Pastore F, Dominici L, Longo S, Cacciola A, Ciabattoni A, Zamagni A, Francolini G, Fontana A, Scipilliti E, Mazzola R, D\u2019Angelo E, Ingargiola R, Muto P, Maranzano E (2023) Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO). Clin Transl Oncol 25(2):408\u2013416. https:\/\/doi.org\/10.1007\/s12094-022-02951-3","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"10304_CR27","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/neuonc\/noad169","volume":"25","author":"B Nabors","year":"2023","unstructured":"Nabors B, Portnow J, Hattangadi-Gluth J, Horbinski C (2023) NCCN CNS tumor guidelines update for 2023. Neuro Oncol 25(12):2114\u20132116. https:\/\/doi.org\/10.1093\/neuonc\/noad169","journal-title":"Neuro Oncol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-024-10304-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T04:45:44Z","timestamp":1729745144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-024-10304-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10304"],"URL":"https:\/\/doi.org\/10.1007\/s10585-024-10304-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"all authors agree for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All Authors declare no competing interests for this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}